First HIV - Search News

HIV, annual injection

MIT Technology Review · 1d

This annual shot might protect against HIV infections

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Interesting Engineering on MSN · 3d

Revolutionary HIV injection could offer a full year of protection in just one dose

A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully

Becker's Hospital Review · 2d

HIV drug could offer yearlong protection with a single shot

A new formulation of Gilead's HIV prevention drug, lenacapavir, has shown promise in providing yearlong protection with just one injection. The study, published in The Lancet, evaluated the pharmacokinetics,

El Mundo on MSN · 3d

New advance against HIV: a single annual injection against the infection

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two injections per year to one against HIV. "It is a hopeful step and the study data are positive.

HIV self-testing is easy, effective — and underutilized

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

3don MSN

Annual jab for HIV protection passes trial hurdle

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

The American Journal of Managed Care2d

Addressing and Improving Gaps in HIV Care for Children and Adolescents

Early diagnosis and prompt antiretroviral therapy initiation are critical for children due to the rapid progression of HIV in ...

1don MSN

HIV's latent reservoir: New insights into Nef protein offer potential strategy to improve treatment

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results